v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses    
Research and development $ 7,197,257 $ 1,946,450
General and administrative 4,562,305 4,205,800
Total operating expenses 11,759,562 6,152,250
Operating loss (11,759,562) (6,152,250)
Other (income) expense    
Interest expense 1,452 436,936
Interest income (619,054) (427,554)
Gain on sale of asset 0 (1,145,141)
Other (income) expense (40,641) 1,040
Total other (income) expense, net (658,243) (1,134,719)
Loss before income taxes (11,101,319) (5,017,531)
Provision for income taxes 2,000 2,000
Net loss $ (11,103,319) $ (5,019,531)
Loss per common share:    
Basic (in dollars per share) $ (0.28) $ (0.18)
Diluted (in dollars per share) $ (0.28) $ (0.18)
Weighted average shares of common stock outstanding used to compute loss per share:    
Basic (in shares) 39,651,888 27,999,901
Diluted (in shares) 39,651,888 27,999,901

Source